Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-28T12:54:13.587Z Has data issue: false hasContentIssue false

Methicillin-Resistant Staphylococcus aureus, Public Concern, and Legislative Mandates

Published online by Cambridge University Press:  02 January 2015

Nevio Cimolai*
Affiliation:
Department of Pathology and Laboratory Medicine, Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada
*
Department of Pathology and Laboratory Medicine, Children's and Women's Health Centre of British Columbia, 4480 Oak Street, Vancouver, BC, V6H3V4, Canada ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

References

1.Weber, SG, Huang, SS, Oriola, S, et al.Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007;28:249260.CrossRefGoogle ScholarPubMed
2.Boyce, JM, Causey, WA. Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control 1982;3:377383.CrossRefGoogle ScholarPubMed
3.National Statistics. Deaths involving MRSA: England and Wales, 2001-2005. Health Stat Q 2007;33:7681.Google Scholar
4.Gould, IM. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents 2006;28:379384.CrossRefGoogle ScholarPubMed
5.Washer, P, Joffe, H. The “hospital superbug”: social representations of MRSA. Soc Set Med 2006;63:21412152.CrossRefGoogle ScholarPubMed